CVS HEALTH CORPORATION Liability for Claims and Claims Adjustment Expense
CVS HEALTH CORPORATION (CVS) had Liability for Claims and Claims Adjustment Expense of $12.55 billion as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Balance Sheet › Liabilities
us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense · last filed 2024-02-07
- 2023-09-30: Liability for Claims and Claims Adjustment Expense $12.55B.
- 2023-06-30: Liability for Claims and Claims Adjustment Expense $12.00B.
- 2023-03-31: Liability for Claims and Claims Adjustment Expense $10.89B.
- 2022-12-31: Liability for Claims and Claims Adjustment Expense $10.14B; Liability for Claims and Claims Adjustment Expense as first filed $10.41B.
| Period end | Liability for Claims and Claims Adjustment Expense | Liability for Claims and Claims Adjustment Expense as first filed |
|---|---|---|
| 2023-09-30 | $12.55B 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $12.00B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $10.89B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $10.14B 10-K · filed 2024-02-07 | $10.41B 10-K · filed 2023-02-08 |
| 2022-09-30 | $10.35B 10-Q · filed 2022-11-02 | |
| 2021-12-31 | $8.68B 8-K · filed 2023-05-25 | $8.81B 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |